[go: up one dir, main page]

MX2010003521A - Un proceso para la resolucion quiral de 1,3-oxatiolanos 2 sustituidos 4-sustituidos. - Google Patents

Un proceso para la resolucion quiral de 1,3-oxatiolanos 2 sustituidos 4-sustituidos.

Info

Publication number
MX2010003521A
MX2010003521A MX2010003521A MX2010003521A MX2010003521A MX 2010003521 A MX2010003521 A MX 2010003521A MX 2010003521 A MX2010003521 A MX 2010003521A MX 2010003521 A MX2010003521 A MX 2010003521A MX 2010003521 A MX2010003521 A MX 2010003521A
Authority
MX
Mexico
Prior art keywords
substituted
oxathiolanes
chiral resolution
derivatives
relates
Prior art date
Application number
MX2010003521A
Other languages
English (en)
Inventor
Widanagamage Ruwansiri Epa
Sebastian Mario Marcuccio
John Joseph Deadman
Original Assignee
Avexa Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007905335A external-priority patent/AU2007905335A0/en
Application filed by Avexa Ltd filed Critical Avexa Ltd
Publication of MX2010003521A publication Critical patent/MX2010003521A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invenci?n se relaciona a un proceso novedoso para la resoluci?n quiral de 1,3-oxatiolanos 2-sustituidos 4-sustituidos y derivados de los mismos. La presente invenci?n tambi?n se relaciona a derivados de 1,3-oxatiolanos 2-sustituidos 4-sustituidos novedosos.
MX2010003521A 2007-09-28 2008-09-26 Un proceso para la resolucion quiral de 1,3-oxatiolanos 2 sustituidos 4-sustituidos. MX2010003521A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2007905335A AU2007905335A0 (en) 2007-09-28 A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
US98125207P 2007-10-19 2007-10-19
PCT/AU2008/001433 WO2009039582A1 (en) 2007-09-28 2008-09-26 A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes

Publications (1)

Publication Number Publication Date
MX2010003521A true MX2010003521A (es) 2010-04-27

Family

ID=40510677

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003521A MX2010003521A (es) 2007-09-28 2008-09-26 Un proceso para la resolucion quiral de 1,3-oxatiolanos 2 sustituidos 4-sustituidos.

Country Status (16)

Country Link
US (1) US8318934B2 (es)
EP (1) EP2190839B1 (es)
JP (1) JP5577251B2 (es)
KR (1) KR101374635B1 (es)
CN (1) CN101842370B (es)
AU (1) AU2008303073B2 (es)
BR (1) BRPI0817481A2 (es)
CA (1) CA2700653C (es)
ES (1) ES2542154T3 (es)
IL (1) IL204596A (es)
IN (1) IN2015DN02599A (es)
MX (1) MX2010003521A (es)
NZ (1) NZ584193A (es)
RU (1) RU2494098C2 (es)
WO (1) WO2009039582A1 (es)
ZA (1) ZA201001951B (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587480A (en) * 1990-11-13 1996-12-24 Biochem Pharma, Inc. Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties
RU2244712C2 (ru) * 1998-08-12 2005-01-20 Гайлид Сайенсиз, Инк. Способ получения 1,3-оксатиоланового нуклеозида, способ получения производного 1,3-оксатиоланил-5-она
PL218777B1 (pl) * 2001-06-15 2015-01-30 Shire Canada Inc Stereoselektywny sposób wytwarzania nukleozydów
US7968703B2 (en) * 2005-03-07 2011-06-28 Shire Canada Inc. Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof
MX2007011274A (es) * 2005-03-14 2008-03-13 Shire Canada Inc Procesos y metodos para la preparacion de cis-2-hidroximetil-4-(ci tosin-1-il)-1,3-oxatiolano opticamente activas o sales aceptables farmaceuticamente del mismo.
KR20070080108A (ko) * 2006-02-06 2007-08-09 주식회사종근당 질소의 알파 위치에 비대칭탄소가 있는 라세믹 유도체의광학 이성질체 분리 방법

Also Published As

Publication number Publication date
US20100305321A1 (en) 2010-12-02
IN2015DN02599A (es) 2015-09-18
EP2190839A4 (en) 2011-10-26
ZA201001951B (en) 2011-05-25
EP2190839A1 (en) 2010-06-02
CA2700653A1 (en) 2009-04-02
US8318934B2 (en) 2012-11-27
NZ584193A (en) 2011-07-29
IL204596A0 (en) 2010-11-30
KR20100075964A (ko) 2010-07-05
AU2008303073A1 (en) 2009-04-02
CA2700653C (en) 2013-11-26
RU2494098C2 (ru) 2013-09-27
CN101842370A (zh) 2010-09-22
JP5577251B2 (ja) 2014-08-20
EP2190839B1 (en) 2015-04-15
RU2010116776A (ru) 2011-11-10
BRPI0817481A2 (pt) 2017-05-16
ES2542154T3 (es) 2015-07-31
WO2009039582A1 (en) 2009-04-02
JP2010540467A (ja) 2010-12-24
KR101374635B1 (ko) 2014-03-14
CN101842370B (zh) 2014-02-19
AU2008303073B2 (en) 2012-08-09
IL204596A (en) 2013-08-29

Similar Documents

Publication Publication Date Title
MX2010005557A (es) Derivados de indolinona y procedimiento para su fabricacion.
MX2007014172A (es) Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos.
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
MA32296B1 (fr) Derives de piperidine 3,4-substitues comme inhibiteurs de la renine
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
MX2009013921A (es) Material refractario sin forma, un proceso para producir un material refractario sin forma, humedo como la tierra, y al uso del material refractario sin forma.
PL2060568T3 (pl) Odmiany polimorficzne enancjomerycznie czystej erdosteiny
ZA201009160B (en) Process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives
MX345142B (es) Derivados de aminoalquilpirimidina como antagonistas del receptor h4 de histamina.
ZA201000394B (en) Process and intermediates for the synthesis of 1,2-substituted 3,4-dioxo-1-cyclobutene compounds
SI2225232T1 (sl) Postopek za pripravo substituiranih 1,3-oksatiolanov
MX2010003056A (es) Polimorfos de valomaciclovir.
IN2015DN02599A (es)
WO2009152474A3 (en) Process for the preparation of (3s)-3-amino-n-cyclopropyl-2-hydroxyalkanamide derivatives
MX2007013872A (es) Procedimiento para la produccion de 4-bifenililazetidina-2-onas.
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser
WO2008061238A3 (en) Processes for production of 4-biphenylyazetidin-2-ones
GB0711250D0 (en) Furanose derivatives
MX2009014191A (es) Procedimiento para la preparacion de derivados de dioxazina.
AU2007905335A0 (en) A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
HK1144434A (en) A process for chiral resolution of 2-substituted 4-substituted 1,3-oxathiolanes
MX2009003196A (es) Proceso para la preparacion de y-butirolactonas.
TW200640856A (en) Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzylether derivatives
IL206613A0 (en) Process for the production of 4-(substituted phenyl) hexahydropyrido[2,1-c][1,4]oxazin-6-one

Legal Events

Date Code Title Description
FG Grant or registration